{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T11:30:00Z","timestamp":1793705400678,"version":"4.5.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>Pediatric neurology has undergone a profound transformation over the past two decades. Alongside traditional diagnostic tools such as neuroimaging, electroencephalography, and cerebrospinal fluid analysis, next-generation sequencing has emerged as a central component of clinical evaluation. Simultaneously, the field has shifted from predominantly symptomatic management toward disease-specific and precision-based therapies. This review synthesizes recent advances in neurogenomics and discusses their implications for the future of pediatric neurology and pediatric medicine more broadly.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Broad genetic testing, including exome and genome sequencing, is increasingly considered standard of care for many neurodevelopmental and neurological phenotypes, including developmental delay, autism, epilepsy, neuromuscular disorders, and stroke. For selected exome-negative cases, emerging approaches such as long-read sequencing, transcriptomics, metabolomics, and functional studies may further improve diagnostic yield. Therapeutic advances now include enzyme replacement therapies, antisense oligonucleotides, and gene therapies, with several interventions already FDA-approved and many others in clinical development. As these therapies expand, posttherapy surveillance and development of institutional expertise become increasingly important.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Genomics is rapidly becoming an essential component of day-to-day pediatric neurology practice rather than a niche research discipline. Preparing the workforce through initiatives such as the Child Neurology Society Genetics Curriculum and partnering with patient advocacy organizations will be critical to ensuring equitable implementation of genomic medicine and precision therapeutics.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mop.0000000000001606","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T19:00:47Z","timestamp":1785438047000},"page":"615-623","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A new era of integration of genetics and neurology"],"prefix":"10.1097","volume":"38","author":[{"given":"Kuntal","family":"Sen","sequence":"first","affiliation":[{"name":"Children's National Hospital, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gropman","sequence":"additional","affiliation":[{"name":"St. Jude Children's Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cansu","family":"Ensert Cihan","sequence":"additional","affiliation":[{"name":"Children's Hospital of Michigan, Detroit, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Rajan","sequence":"additional","affiliation":[{"name":"University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis T.","family":"Dang","sequence":"additional","affiliation":[{"name":"University of Michigan, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"R1-20261103","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11910-016-0703-0","article-title":"Neurogenetics in child neurology: redefining a discipline in the twenty-first century","volume":"16","author":"Kaufmann","year":"2016","journal-title":"Curr Neurol Neurosci Rep"},{"key":"R2-20261103","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ncl.2021.05.003","article-title":"Genetic testing and counseling and child neurology","volume":"39","author":"Sadat","year":"2021","journal-title":"Neurol Clin"},{"key":"R3-20261103","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.pediatrneurol.2025.11.021","article-title":"Survivorship in child neurology: a transformative era","volume":"175","author":"Sen","year":"2026","journal-title":"Pediatr Neurol"},{"key":"R4-20261103","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.spen.2012.09.004","article-title":"Updates in the genetic evaluation of the child with global developmental delay or intellectual disability","volume":"19","author":"Flore","year":"2012","journal-title":"Semin Pediatr Neurol"},{"key":"R5-20261103","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1038\/s41436-021-01242-6","article-title":"Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)","volume":"23","author":"Manickam","year":"2021","journal-title":"Genet Med"},{"key":"R6-20261103","doi-asserted-by":"crossref","first-page":"e903","DOI":"10.1542\/peds.2014-1839","article-title":"Comprehensive evaluation of the child with intellectual disability or global developmental delays","volume":"134","author":"Moeschler","year":"2014","journal-title":"Pediatrics"},{"key":"R7-20261103","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/jgc4.1646","article-title":"Genetic testing and counseling for the unexplained epilepsies: an evidence-based practice guideline of the National Society of Genetic Counselors","volume":"32","author":"Smith","year":"2023","journal-title":"J Genet Couns"},{"key":"R8-20261103","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/humu.24347","article-title":"Genome sequencing demonstrates high diagnostic yield in children with undiagnosed global developmental delay\/intellectual disability: a prospective study","volume":"43","author":"Sun","year":"2022","journal-title":"Hum Mutat"},{"key":"R9-20261103","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41576-020-0236-x","article-title":"Long-read human genome sequencing and its applications","volume":"21","author":"Logsdon","year":"2020","journal-title":"Nat Rev Genet"},{"key":"R10-20261103","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/jimd.12506","article-title":"Diagnosis and discovery: insights from the NIH Undiagnosed Diseases Program","volume":"45","author":"Montano","year":"2022","journal-title":"J Inherit Metab Dis"},{"key":"R11-20261103","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1001\/jamapediatrics.2021.3496","article-title":"Effect of whole-genome sequencing on the clinical management of acutely ill infants with suspected genetic disease: a randomized clinical trial","volume":"175","author":"Krantz","year":"2021","journal-title":"JAMA Pediatr"},{"key":"R12-20261103","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41525-018-0053-8","article-title":"Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases","volume":"3","author":"Clark","year":"2018","journal-title":"NPJ Genom Med"},{"key":"R13-20261103","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41525-024-00404-0","article-title":"Rapid genomic sequencing for genetic disease diagnosis and therapy in intensive care units: a review","volume":"9","author":"Kingsmore","year":"2024","journal-title":"NPJ Genom Med"},{"key":"R14-20261103","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.ajhg.2021.05.008","article-title":"Project Baby Bear: rapid precision care incorporating rWGS in 5 California children's hospitals demonstrates improved clinical outcomes and reduced costs of care","volume":"108","author":"Dimmock","year":"2021","journal-title":"Am J Hum Genet"},{"key":"R15-20261103","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3390\/ijns7040076","article-title":"Select ethical aspects of next-generation sequencing tests for newborn screening and diagnostic evaluation of critically ill newborns","volume":"7","author":"Sen","year":"2021","journal-title":"Int J Neonatal Screen"},{"key":"R16-20261103","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/ijns10030054","article-title":"A five-year review of newborn screening for spinal muscular atrophy in the state of Utah: lessons learned","volume":"10","author":"Wong","year":"2024","journal-title":"Int J Neonatal Screen"},{"key":"R17-20261103","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/ijns8010016","article-title":"Newborn screening for X-linked adrenoleukodystrophy: past, present, and future","volume":"8","author":"Moser","year":"2022","journal-title":"Int J Neonatal Screen"},{"key":"R18-20261103","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1056\/NEJMoa1712649","article-title":"Study of intraventricular cerliponase alfa for CLN2 disease","volume":"378","author":"Schulz","year":"2018","journal-title":"N Engl J Med"},{"key":"R19-20261103","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ymgme.2022.07.017","article-title":"Intrathecal idursulfase-IT in patients with neuronopathic mucopolysaccharidosis II: results from a phase 2\/3 randomized study","volume":"137","author":"Muenzer","year":"2022","journal-title":"Mol Genet Metab"},{"key":"R20-20261103","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/epi.16438","article-title":"Biological concepts in human sodium channel epilepsies and their relevance in clinical practice","volume":"61","author":"Brunklaus","year":"2020","journal-title":"Epilepsia"},{"key":"R21-20261103","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus sham control in infantile-onset spinal muscular atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"N Engl J Med"},{"key":"R22-20261103","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","article-title":"Trial of antisense oligonucleotide tofersen for SOD1 ALS","volume":"387","author":"Miller","year":"2022","journal-title":"N Engl J Med"},{"key":"R23-20261103","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1001\/jama.2023.18688","article-title":"Eplontersen for hereditary transthyretin amyloidosis with polyneuropathy","volume":"330","author":"Coelho","year":"2023","journal-title":"JAMA"},{"key":"R24-20261103","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-1-0716-4730-1_3","article-title":"An overview of recent advances and clinical applications of exon skipping and splice modulation for muscular dystrophy and various genetic diseases","volume":"2964","author":"Rodrigues","year":"2025","journal-title":"Methods Mol Biol"},{"key":"R25-20261103","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3390\/genes17030318","article-title":"From genomic diagnosis to personalized RNA medicine: advances in next-generation sequencing and N-of-1 antisense oligonucleotide therapies for rare genetic diseases","volume":"17","author":"Rodriguez Carstens","year":"2026","journal-title":"Genes (Basel)"},{"key":"R26-20261103","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S1474-4422(21)00251-9","article-title":"Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial","volume":"20","author":"Mercuri","year":"2021","journal-title":"Lancet Neurol"},{"key":"R27-20261103","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.ymthe.2026.01.004","article-title":"Incidence, timing, and clinical significance of adverse immune events after gene replacement therapy: a systematic review and meta-analysis","volume":"34","author":"Maurizi","year":"2026","journal-title":"Mol Ther"},{"key":"R28-20261103","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3390\/genes17030275","article-title":"Genetics and genomics of pediatric neurological disorders: an overview of current insights and future directions","volume":"17","author":"Trabacca","year":"2026","journal-title":"Genes (Basel)"},{"issue":"(8\u20139)","key":"R29-20261103","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1177\/08830738221106896","article-title":"Gaps in neurogenetics education during child neurology residency: results of a national survey","volume":"37","author":"Sen","year":"2022","journal-title":"J Child Neurol"},{"key":"R30-20261103","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pediatrneurol.2023.12.017","article-title":"Targeted needs assessment for a national neurogenetics curriculum","volume":"152","author":"Gottlieb-Smith","year":"2024","journal-title":"Pediatr Neurol"},{"key":"R32-20261103","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.pediatrneurol.2026.04.002","article-title":"Emerging topics in neurogenomics: summary from Inaugural Child Neurology Society Genetics Summit","volume":"180","author":"Sen","year":"2026","journal-title":"Pediatr Neurol"},{"key":"R33-20261103","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/epi.16625","article-title":"Integrating quality improvement into the ECHO model to improve care for children and youth with epilepsy","volume":"61","author":"Joshi","year":"2020","journal-title":"Epilepsia"},{"key":"R34-20261103","doi-asserted-by":"crossref","first-page":"e70057","DOI":"10.1002\/jgc4.70057","article-title":"A landscape assessment of Medicaid recognition for genetic counselors","volume":"34","author":"Reys","year":"2025","journal-title":"J Genet Couns"},{"issue":"(Suppl 3)","key":"R35-20261103","doi-asserted-by":"crossref","first-page":"S788","DOI":"10.1007\/s11606-014-2895-9","article-title":"A systematic review of approaches for engaging patients for research on rare diseases","volume":"29","author":"Forsythe","year":"2014","journal-title":"J Gen Intern Med"},{"key":"R36-20261103","first-page":"502","article-title":"Involvement of patient organisations in research and development of orphan drugs for rare diseases in Europe","volume":"6","author":"Haffner","year":"2018","journal-title":"Mol Genet Genomic Med"},{"key":"R37-20261103","first-page":"1078","article-title":"Patient-centered drug approval: the role of patient advocacy in the drug approval process","volume":"23","author":"Mattingly","year":"2017","journal-title":"J Manag Care Spec Pharm"},{"key":"R38-20261103","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/MLR.0000000000000273","article-title":"Patient-focused drug development: a new direction for collaboration","volume":"53","author":"Perfetto","year":"2015","journal-title":"Med Care"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MOP.0000000000001606","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T11:00:29Z","timestamp":1793703629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MOP.0000000000001606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000001606","relation":{},"ISSN":["1531-698X","1040-8703"],"issn-type":[{"value":"1531-698X","type":"electronic"},{"value":"1040-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,5]]}}}